Shinya Rai

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Anas Younes, Laurie H. Sehn, Peter Johnson et al. · Journal of Clinical Oncology · 2019 · 616 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Koji Izutsu, Shinichi Makita, Kisato Nosaka et al. · Blood · 2022 · 156 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo et al. · Nature · 2023 · 108 citations · Full text

Medicine, Cancer Biology, Oncology +14

A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia

Naohiro Sekiguchi, Shinya Rai, Wataru Munakata et al. · Cancer Science · 2020 · 77 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice

Mai Suzuki, Hirokazu Tanaka, Akira Tanimura et al. · PLoS ONE · 2012 · 61 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17